These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6627241)

  • 21. Studies with ifosfamide in patients with malignant lymphoma.
    Rodriguez V; Cabanillas F; Bodey GP; Freireich EJ
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):87-92. PubMed ID: 7163815
    [No Abstract]   [Full Text] [Related]  

  • 22. Ifosfamide in pediatric oncology.
    Voûte PA; de Kraker J
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):2-6. PubMed ID: 1411617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use and safety of high-dose ifosfamide.
    Holoye PY; Anderson T; Duelge J; Hansen RM; Ritch PS
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):78-86. PubMed ID: 6298946
    [No Abstract]   [Full Text] [Related]  

  • 24. Ifosfamide vs cyclophosphamide in cancer therapy.
    Weiss RB
    Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease.
    Sutton GP; Soper JT; Blessing JA; Hatch KD; Barnhill DR
    Am J Obstet Gynecol; 1992 Aug; 167(2):489-95. PubMed ID: 1323213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse of adult acute lymphoblastic leukaemia treated with ifosfamide combination chemotherapy.
    Timonen TT
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():145-50. PubMed ID: 6578874
    [No Abstract]   [Full Text] [Related]  

  • 27. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial.
    Gandola L; Pozzi E; Tansini G
    G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387
    [No Abstract]   [Full Text] [Related]  

  • 28. Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
    Prescrire Int; 1998 Apr; 7(34):45-7. PubMed ID: 10183382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised trial comparing sequential methotrexate (or 5-FU), vinblastine and ifosfamide to vincristine, adriamycin and ifosfamide in advanced lung cancer.
    Focan C; Le Hung S; Bays-Gallaix R; Frere MH; Demonceau G; Mbuyamba P; Claessens JJ
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():103-10. PubMed ID: 6354441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ifosfamide in non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide (with mesna), vincristine and cis-platinum for carcinoma of the head and neck.
    Focan C; Le Hung S; Bays-Gallaix R; Frère MH; Demonceau G; Mbuyamba P; Salamon E; Claessens JJ
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():159-61. PubMed ID: 6684990
    [No Abstract]   [Full Text] [Related]  

  • 32. Interstitial pneumonitis associated with ifosfamide therapy.
    Baker WJ; Fistel SJ; Jones RV; Weiss RB
    Cancer; 1990 May; 65(10):2217-21. PubMed ID: 2112039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of ifosfamide in the treatment of lymphomas.
    Hagemeister FB
    Leuk Lymphoma; 1999 Aug; 34(5-6):433-41. PubMed ID: 10492066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ifosfamide.
    Zalupski M; Baker LH
    J Natl Cancer Inst; 1988 Jun; 80(8):556-66. PubMed ID: 3286879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
    Schnitker J; Brock N; Burkert H; Fichtner E
    Arzneimittelforschung; 1976; 26(10):1783-92. PubMed ID: 798586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
    Ettinger DS; Finkelstein DM; Ritch PS; Lincoln ST; Blum RH;
    Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anticancer spectrum of ifosfamide.
    Hunter HL; Harrison EF
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):96-100. PubMed ID: 6761868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.